Search Results 21-30 of 17040 for hla genotype
5 genotype (HLA-DQA1*05 and HLA-DQB1*02) (homozygous or heterozygous) ... genotyping must submit a blood sample to determine whether an eligible HLA-DQ2.
In our first aim, we will evaluate the associations between maternal-infant HLA alleles, eplets and VUE. ... Abnormal genotype. Note: Other protocol ...
The purpose of the observational study is to determine the HLA-DR/DQ mMM score accurately stratifies kidney transplant recipients into low, intermediate, and ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
A Study To Evaluate The Safety And Efficacy Of A2B395, An Allogeneic Logic-gated CAR T, In Participants With Solid Tumors That Express EGFR And Have Lost HLA-A* ...
A Study To Evaluate The Safety And Efficacy Of Mesothelin-Targeting Logic-gated CAR T, In Participants With Solid Tumors That Express MSLN And Have Lost HLA-A* ...
... HLA-A, HLA-B, HLA-C, and HLA-DRB1. Fulfillment of this criterion shall be considered sufficient evidence that the donor and recipient share one HLA ...
HLA genotype in patients with acquired haemophilia A. Pavlova A. A; Zeitler H. H; Scharrer I. I; Brackmann HH. H-H; Oldenburg J. J. Haemophilia : the ...
The participant is positive for the human leukocyte antigen (HLA) genotype HLA-DQB1*06:02 or results from radioimmunoassay indicate the participant's ...
The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!